A microRNA (mmu-miR-124) prevents Sox9 expression in developing mouse ovarian cells by Real, F.M. et al.
BIOLOGY OF REPRODUCTION (2013) 89(4):78, 1–11
Published online before print 14 August 2013.
DOI 10.1095/biolreprod.113.110957
A MicroRNA (mmu-miR-124) Prevents Sox9 Expression in Developing Mouse Ovarian
Cells1
Francisca M. Real,3 Ryohei Sekido,4 Darı´o G. Lupia´n˜ez,3 Robin Lovell-Badge,4 Rafael Jime´nez,2,3 and
Miguel Burgos3
3Departamento de Gene´tica e Instituto de Biotecnologı´a, Universidad de Granada, Centro de Investigacio´n Biome´dica,
Granada, Spain
4Division of Stem Cell Biology and Developmental Genetics, Medical Research Council National Institute for Medical
Research, Mill Hill, London, United Kingdom
ABSTRACT
In mammals, sex differentiation depends on gonad develop-
ment, which is controlled by two groups of sex-determining
genes that promote one gonadal sex and antagonize the opposite
one. SOX9 plays a key role during testis development in all
studied vertebrates, whereas it is kept inactive in the XX gonad
at the critical time of sex determination, otherwise, ovary-to-
testis gonadal sex reversal occurs. However, molecular mech-
anisms underlying repression of Sox9 at the beginning of ovarian
development, as well as other important aspects of gonad
organogenesis, remain largely unknown. Because there is
indirect evidence that micro-RNAs (miRNA) are necessary for
testicular function, the possible involvement of miRNAs in
mammalian sex determination deserved further research. Using
microarray technology, we have identified 22 miRNAs showing
sex-specific expression in the developing gonads during the
critical period of sex determination. Bioinformatics analyses led
to the identification of miR-124 as the candidate gene for
ovarian development. We knocked down or overexpressed miR-
124 in primary gonadal cell cultures and observed that miR-124
is sufficient to induce the repression of both SOX9 translation
and transcription in ovarian cells. Our results provide the first
evidence of the involvement of a miRNA in the regulation of the
gene controlling gonad development and sex determination. The
miRNA microarray data reported here will help promote further
research in this field, to unravel the role of other miRNAs in the
genetic control of mammalian sex determination.
cell transfection, gene expression, gonad development,
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INTRODUCTION
The process of sex determination involves mechanisms that
prompt the undifferentiated embryonic gonad to follow either
of the two alternative developmental pathways, the testis or the
ovary. A single gene located on the Y chromosome, the sex-
determining region of the Y (SRY) gene, is the switch for sex
determination in almost all mammals [1–3]. In XY mice,
shortly after the expression of Sry in somatic cells of the
supporting cell lineage of the gonad, testis development begins
with the differentiation of these cells as pre-Sertoli cells located
in the testis cords that also enclose the primordial germ cells.
Several additional cellular events also occur outside the testis
cords, including mesonephric cell migration, testis-specific
vascularization, and differentiation of Leydig and peritubular
myoid cells [see refs. 4 and 5 for reviews]. In females, the
genetic pathways for ovary development are largely unknown
to date.
Many genes are currently known to be involved in gonadal
development [6–8]. Expression of SRY-related HMG-box,
gene 9 (SOX9) is essential for normal testis development in
most vertebrates. Ectopic expression of Sox9 in the gonads of
XX mice leads to a female-to-male sex reversal with the
formation of XX testes [9, 10], and XY mice lacking Sox9
expression develop ovaries, thus showing a male-to-female sex
reversal [11, 12]. Hence, Sox9, like Sry, is necessary and
sufficient to trigger testis organogenesis. A positive feedback
loop between Sox9 and fibroblast growth factor 9 (Fgf9) is
initiated by Sry, which results in the up-regulation of Fgf9 and
the repression of wingless-type MMTV integration site family,
member 4 (Wnt4) in the male gonad [13]. This is crucial for the
maintenance of testis development, because Wnt4 represses the
migration of endothelial and steroidogenic cells from the
mesonephros to the XX gonad [14], probably by activating the
b-catenin signaling pathway. The fact that XY Fgf9/Wnt4
double mutants developed testes indicates that the primary role
of Fgf9 is the repression of Wnt4 and suggests that the Sox9/
Fgf9 positive feedback loop is established through Wnt4, thus
Fgf9 repressing a Sox9 repressor [15].
Ovarian differentiation was assumed to be the default
pathway in gonad development. However, several discoveries
have shown that the ovarian phenotype, once determined, must
be actively maintained throughout life. Although Foxl2 is
required to maintain the ovarian phenotype at the postnatal
stage [16], little is known on how ovary differentiation is
initiated at the embryonic stage after sex determination. Sex
determination is established in terms of a balance between
Fgf9- and Wnt4-expression predominance. It is known that Sry
tips the balance toward the testis pathway in males, and Wnt
signaling may have a similar role in females. R-spondin family
member 1 (RSPO1), which, like Wnt4, serves to stabilize b-
catenin, appears sufficient to block the testicular pathway in
some XX humans [17], although this is not the case in mice,
where XX Rspo1 null mutant gonads have a phenotype similar
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to that of Wnt4 null mutants [18]. Available data suggest that
Rspo1 may cooperate with Wnt4 to stabilize b-catenin, helping
to counteract the establishment of the Sox9/Fgf9 positive
feedback loop during mouse ovarian development (see
reference [19] for a review). Indeed, mice carrying a
constitutive active form of b-catenin show XY female sex
reversal [20].
Before sex determination, Sox9 expression occurs at a basal
level in both male and female gonadal primordia, but at 11.5
days postcoitum (dpc), it is up-regulated in males and down-
regulated in females [21]. The regulatory action of SRY on
Sox9 has recently been unraveled. SRY, in a synergistic action
with NR5A1/SF1, up-regulates Sox9 in male undifferentiated
gonads by binding to a testis-specific Sox9 enhancer [22].
However, it is not known how Sox9 is down-regulated in the
female gonad. Although Wnt4 null mutant XX gonads can
show transient upregulation of Sox9 expression [13], null
mutations in either the gene for b-catenin (Ctnnb1) or Foxl2 are
not sufficient to maintain de-repression of Sox9 expression in
the early XX gonad and neither are compound null mutations
involving Wnt4 and Foxl2, or Rspo1 and Foxl2 [23, 24] (see
also our unpublished data). All this suggests that additional
genetic elements other than those currently known are involved
in sex determination, especially those required to drive ovary
and repress testis differentiation. In this context, several studies
have suggested that micro-RNAs (miRNAs) are involved in
this process, but this hypothesis has not yet been sufficiently
explored.
MicroRNAs are small, noncoding RNAs that regulate the
expression of target genes, either by guiding the cleavage of
their target mRNAs or by inhibiting their translation [25–28].
miRNAs have been shown to exert post-transcriptional control
of genes involved in development and other biological aspects
including disease, cell death, cell proliferation and hematopoi-
esis, in a variety of organisms, including Caenorhabditis
elegans, flies, mammals and plants [26, 29–34]. Although no
miRNA is currently known to play a role in vertebrate sex
determination, there is indirect evidence to suggest that miRNA
could be involved in the process: several miRNAs show a
sexually dimorphic expression pattern in the mouse gonad at
13.5 dpc [35]; and targeted disruption of Dicer1, a gene
involved in miRNA maturation, has revealed that Dicer protein
is necessary to maintain Sertoli cell function [36–38].
MATERIALS AND METHODS
Animals and Gonadal Cells
Gonads were dissected from Swiss, Parkes, and CD1 outbred mouse
embryos at 11.5 and 13.5 dpc and were either fixed or prepared for cell culture.
Individual embryos were sexed either by gonad morphology (at 13.5 dpc) or at
earlier indifferent stages using sex chromatin staining of amniotic cells [39] and
duplex PCR for zinc finger protein 1, Y linked (Zfy1) and the gene for
myogenin (Myog). For purification of the RNA used in microarray experiments,
a total of 24 male 11.5 dpc, 19 male 13.5 dpc, 31 female 11.5 dpc, and 18
female 13.5 dpc gonads were unambiguously identified, pooled, and processed
(see later discussion). For transfection studies, sexed male and female gonads
were pooled, disaggregated both mechanically and enzymatically (125 lg/ml
collagenase; Roche) and cultured either in LabTek chamber slides or in 24-well
plates, using Dulbecco modified Eagle medium (DMEM; Sigma) with 10%
fetal calf serum (FCS, Sigma). Similarly, primary chondrocyte cultures were
from mouse embryonic limbs. For in situ hybridization, sexed gonads were
fixed overnight in 4% paraformaldehyde and further immersed in 30% sucrose
(w/v), embedded in Tissue-Tek optimal cutting temperature compound
(Sakura) and sectioned in a cryostat. Mouse housing and handling, as well as
laboratory protocols, were approved by the University of Granada Ethics
Committee for Animal Experimentation or were carried out under a U.K. Home
Office Project License.
MicroRNA Profiling of Mouse Gonads
Total RNA from embryonic gonads at 11.5 and 13.5 dpc was purified using
a miRNeasy mini kit (Qiagen) according to the manufacturer’s protocol.
Further steps were performed by Exiqon miRNA Profiling Service. The quality
and integrity of the RNA samples was assessed in a Bioanalyser 2100 (Agilent
Technologies), and the concentration was measured with a spectrophotometer
(Nanodrop). All samples used for array hybridization showed RNA integrity
numbers higher than 9. Micro-RNA samples were labeled using a miRCURY
Hy3/Hy5 power labeling kit from Exiquon. Four embryo gonad samples were
analyzed: male 11.5 dpc, female 11.5 dpc, male 13.5 dpc, and female 13.5 dpc.
Each sample was labeled with Hy3 and double hybridized against a pool of the
four samples labeled with Hy5, which was used as a common reference.
Hybridizations were performed with an HS400/4800 hybridization station
(Exiqon-Tecan). The miRCURY locked nucleic acid (LNA) microarray slides
were scanned using a G2565BA microarray scanner system (resolution 10 lm;
Agilent Technologies).
Array Slide Quality Control Using Spike-Ins
Hy3 and Hy5 labeling reactions, hybridization, and performance of array
experiment were evaluated with RNA controls (spike-in) added at various
concentrations, covering the full signal range, to the labeling reactions. A high
correlation for both the Hy3 and the Hy5 channels indicated that both labeling
and hybridization were successful. Each spike-in control had 32 replicates of
capture probes on the array.
MicroRNA Microarray Data Validation
Data from selected micro-RNAs were validated in our laboratory by real-
time RT-PCR using the miRCURY LNA micro-RNA PCR system (Exiqon), in
a Chromo4 real-time thermocycler (Bio-Rad) according to Exiqon protocols.
As primer sets specific for the amplification of miR-124 were not available
from Exiqon, microarray data from this micro-RNA were validated using
TaqMan micro-RNA assays from Applied Biosystems, according to the
manufacturer’s procedures. For miR-124, three gene expression quantification
experiments were performed with different gonadal RNA samples, and each
quantitative (Q)-RT-PCR assay was done in triplicate using the U6 snRNA as a
reference. MIAME-compliant data were submitted to ArrayExpress accession:
E-MEXP-2252, experiment name: Expression of miRNAs in mouse embryo
gonad during the critical period of sex determination; specified release date:
May 11, 2013.
Identification of Active miR-124 Genes
RT-PCR was used to identify which of the three possible miR-124
precursor transcripts were expressed in the developing gonads. As the predicted
amplification products are short sequences, short oligonucleotides (oligos) were
designed with the eprimer3 application from the emboss package, and the
alignment temperature of the oligos was increased and adjusted, adding
unspecific nucleotides at the 50 end of each oligo. The primers sequences were
as follow: forward 50-GCC TCT CTC TCC GTG T-30 and reverse 50-CCA
TTC TTG GCA TTC A-30 for mmu-miR-124-1; forward 50-AGA GAC TCT
GCT CTC CGT GT-30 and reverse 50-CTC CGC TCT TGG CAT TC-30 for
mmu-mir-124-2; and forward 50-GGC TGC GTG TTC ACA G-30 and reverse
5 0-ATC CCG CGT GCC TTA-3 0 for mmu-mir-124-3. One triplicate
quantitative (Q)-RT-PCR reaction was carried out using RNA samples from
six pooled 13.5 dpc mouse embryonic gonads of each sex.
Bioinformatics
Microarray image analysis was carried out using ImaGene version 7.0
software (BioDiscovery, Inc.). The quantified signals (background correction
Normexp, with offset value 10 [40] were normalized by Exiquon miRNA
Profiling Service, using the global LOcally WEighted Scatterplot Smoothing
(LOWESS) regression algorithm. In order to assess the biological significance
of differentially expressed miRNAs, we searched for putative targets in genes
involved in sex determination or gonad development, fetching miRNA data
from miRbase (http://www.mirbase.org/), gene descriptions from Ensembl
(http://www.ensembl.org/), and filtering the results with Gene Ontology (GO)
terms (http://www.geneontology.org/) by using Perl scripts (http://www.perl.
org/) developed for this purpose. Graphs were drawn and statistics were
analyzed with gnu-R software (http://www.r-project.org/).
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Luciferase Assays
HEK293T cells cultured in 24-well plates were cotransfected using
Lipofectamine 2000 (Invitrogen), with a miR-124 overexpression plasmid
vector (1 lg/well; ref. MmiR3282-MR04; Genecopoeia), and pLuc-Sox9 30-
untranslated region (UTR) (0.2 lg/well). Forty-eight hours after transfection,
cells were harvested for luciferase assay. Dual reporter assays were performed
by measuring both firefly and Renilla luciferase activities (LucPair miR dual
luciferase assay kit; ref. LPFR-M010; Genecopoeia) according to the
manufacturer’s protocols.
MicroRNA In Situ Hybridization
In situ hybridization experiments with a miR-124-specific miRCURY LNA
micro-RNA detection probe (catalog no. 33007-01; sequence: CTTGGCATT
CACCGCGTGCCTTA; provided at 25 lM; Exiqon) were performed. Briefly,
8-lm-long cryosections (four per slide) were hybridized with 30 nM 50-
digoxigenin-labeled LNA probe overnight at 588C. Signals were revealed
using anti-digoxigenin alkaline phosphatase-conjugated antibodies (1:1500
dilution; Roche) and bone morphogenic protein (BMP) purple substrate. In situ
hybridization experiments were performed six times with different gonad
samples. For negative controls, gonad cryosections were subjected to the entire
protocol but the probe was omitted from the hybridization mixture.
MicroRNA Knock-Down and Overexpression in Cultured
Cells
Primary gonadal cell cultures were transfected for miRNA inhibition and
overexpression experiments. The inhibition of miR-124 in XX embryonic
gonad cells was produced with a high-affinity LNA-enhanced probe
(antagomir) for specific in vitro knock-down (ref. 139452-04; miRCURY
LNA micro-RNA inhibitor 50-fluorescein-labeled; from Exiqon). As a negative
control, we transfected the same type of cells with a different antagomir,
specific for miR-144, an miRNA that is not expressed in the female gonad
according to our miRNA microarray data. Cells were plated to a density of
50 000 cells per cm2 in 8-well chamber slides (LabTek) for immunofluores-
cence studies or in 24-well culture plates for further RNA extraction, in 500 ll
of DMEM supplemented with 10% FCS. For transfection with the silencing
probes, cells were transfected for 4–6 h after plating with a mixture of 1.5 ll of
Lipofectamine 2000 (Invitrogen) in 50 ll of Opti-Mem-I reduced serum
medium without antibiotics and 6 ll of probe in 50 ll of Opti-Mem, according
to the guidelines of the manufacturer. After 24 h, the medium was replaced with
DMEM supplemented with 10% FCS and 15 lg/ml tetracycline. Forty-eight
hours later the efficiency of transfection was checked by the fluorescence of the
probe. The efficiency of transfection was higher than 90% in all these
experiments. Seventy-two hours after transfection, the cells were fixed in 4%
formaldehyde or processed for total RNA extraction.
Overexpression of miR-124 was performed using a precursor miRNA
expression clone for the mouse mmu-mir-124-2 gene (ref. MmiR3282-MR04;
Genecopoeia). In this case, cells transfected with a precursor miRNA-
scrambled control clone (ref. CmiR0001-MR04; Genecopoeia) were used as
the negative control. For transfection of primary cultures of embryonic gonad
cells with these vectors, we followed a procedure similar to that described
previously with some exceptions. Before culture, cells were enzymatically
disaggregated with collagenase (250 lg/ml) and then transfected with 1 lg of
vector by using an electroporator (Nucleofector II; Amaxa), obtaining a
transfection efficiency higher than 60%, which was determined by counting the
percentage of fluorescent cells (green fluorescent protein [GFP] was included in
the transfection vector). Forty-eight hours after transfections, cells were either
fixed in 4% formaldehyde or processed for total RNA extraction.
Both knock-down and overexpression experiments were performed more
than five times using 3–4 13.5 dpc pregnant females per experiment, providing
approximately 60 embryonic gonads, which were divided into three sets of 20
gonads each. Cells from the first set were treated with the miR-124-antagomir/
overexpression vector, those from the second set were treated with the miR-
144-antagomir/control vector, and those from the third set remained untreated
before fixation or RNA extraction.
Gene Expression Quantification
To check the genetic effects of the miRNA knock-down experiments by Q-
RT-PCR, total RNA was extracted with Trizol reagent (Qiagen) after
transfection and 300–900 ng total RNA was reverse transcribed using
Superscript II (Invitrogen) and random hexamers as primers. RNA samples
were purified from both nontransfected and transfected cells with the miR-124-
silencing LNA probe. Expression levels of mmu-miR-124 were quantified
using TaqMan micro-RNA assays (Applied Biosystems) according to the
manufacturer’s procedures. Quantification of Sox9 expression levels was
performed using 1-ll aliquots of a 1:10 dilution of the RT reaction as templates
in the Q-PCR reactions. Each PCR reaction was run in triplicate, and all
experiments were repeated at least three times. All samples were normalized
relative to glyceraldehyde-3-phosphate dehydrogenase (Gapdh), using the
2–DDCT (Livak) method. The primers for Sox9 mRNA amplification were
forward 50-CGG AGG AAG TCG GTG AAG A-30 and reverse 50-GTC GGT
TTT GGG AGT GGT G-30. For Gapdh amplification the primers were:
forward 50-GGC ATT GCT CTC AAT GAC AA-30 and reverse 50-TGT
GAGG GAG ATG CTC AGT G-30. The identity of the amplified fragments
was confirmed by sequencing in both cases.
SOX9 Protein Detection
Immunofluorescence analyses were performed to check the presence of
SOX9 protein in transfected gonadal cells. Cells were cultured in LabTek
chamber slides, fixed for 5 min in 4% formaldehyde, washed in PBS, blocked
for 1 h at room temperature with 2% BSA in PBS, and incubated overnight
with a 1:100 dilution of SOX9-specific rabbit primary antibody (two different
antibodies were used, antibody code sc-20095 [Santa Cruz Biotechnology] and
code AF3075 [R&D Systems], and the same results were obtained). Slides were
then washed in PBS and incubated for 1 h at room temperature with a 1:500
dilution of Alexa Fluor 555 goat anti-rabbit secondary antibody (Invitrogen).
Sections were then washed in PBS, incubated in a solution of 100 ng/ml 40,6-
diamidino-2-phenylindole (DAPI) for 30 min at room temperature, washed
again in PBS, and mounted (Vectashield mounting medium; Vector
Laboratories). Images were obtained with an Olympus BX41 microscope with
epifluorescence equipment.
RESULTS
MicroRNA Expression Profiling of Mouse 11.5- and 13.5-
dpc Male and Female Gonads
All data from miRNA microarray profiling experiments in
the present study are provided in Supplemental Data (Project-
Summary.xls; all Supplemental Data are available online at
www.biolreprod.org). Among 757 miRNAs included in the
miRCURY LNA microarray slides, 71 miRNAs showed
differential expression either between sexes or between
developmental stages. The expression profiles of these
miRNAs are shown in a heat map diagram (Fig. 1), as
previously described [41], where rows represent miRNAs and
columns represent different samples. This diagram also
includes a two-way hierarchical clustering of genes and
samples. The miRNA clustering tree, constructed based on
log
2
(Hy3:Hy5) ratios (.0.5 SD among the four samples),
permits identification of five different gene clusters (Fig. 1, A–
E). The miRNAs in clusters A and E are either down-regulated
(Fig. 1A) or up-regulated (Fig. 1E) during the transition
between the two developmental stages (11.5 and 13.5 dpc) but
show no great differences in levels of expression between
testes and ovaries at 13.5 dpc. Therefore, these miRNAs are
probably not involved in gonadal sex differentiation and thus
have little relevance to the current study. In contrast, miRNAs
in clusters B, C, and D, show differential expression in a sex-
specific fashion at 13.5 dpc but not at 11.5 dpc and are
therefore good candidates to be involved in gonadal sex
differentiation. Cluster B includes 3 miRNAs that are up-
regulated in ovaries and down-regulated in testes at 13.5 dpc,
suggesting a potential role in ovarian development. Cluster C
contains six miRNAs that are exclusively up-regulated in 13.5
dpc testes, suggesting a role in testis development. On the other
hand, cluster D consists of 11 miRNAs up-regulated only in
13.5 dpc ovaries and, therefore, similar to those in cluster B;
these miRNAs could be involved in ovarian development.
The outcome of our miRNA microarray profiling experi-
ments was validated by Q-RT-PCR. The expression levels of at
least 2 representative miRNAs of each cluster, except for
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cluster E, were measured and compared with the corresponding
array expression profiles (Fig. 2A and Supplemental Fig. S1).
In general, relative expression levels in microarrays correspond
to those in the Q-RT-PCR assays. Although mmu-miR-126-5p
and mmu-miR-103 were classified as members of cluster A by
the clustering analysis, because differences in expression levels
between developmental stages are higher than those between
sexes at 13.5 dpc, the differential expression in 13.5 dpc male
and female gonads should be taken into account. Thus, we
included these miRNAs in the Q-RT-PCR validation set. Our
results confirmed that the expression of both miRNAs is
significantly higher in females than in males at 13.5 dpc (miR-
103 also at 11.5 dpc), suggesting a potential role in ovarian
development.
Identification of mmu-mir-124 as a Candidate Gene for
Ovarian Development
We performed bioinformatic analyses to investigate the
potential biological role of miRNAs that showed sex-specific
expression and thus to identify new genetic elements involved
in mammalian sex determination. We searched mainly specific
miRNA target sequences in the 30-UTR regions of genes
associated with GO terms such as, sex determination, sex
differentiation, gonad differentiation, testis development, ovary
development, gonad development, Sertoli cell differentiation,
and follicle cell differentiation. Using these criteria, we
identified miR-124 as a good candidate gene for ovarian
development because several genes involved in sex determi-
nation, including Sox9, share potential targets of this miRNA in
their 30-UTR regions. Furthermore, miR-124 was included in
cluster B (differentially expressed in developing ovaries) and is
known to control Sox9 expression in the brain [42]. These data
strongly suggested that miR-124 may play an important role in
early steps of ovarian development, and thus, we carried out
further analyses of this miRNA.
The functional interaction between miR-124 and Sox9 was
examined in the luciferase reporter assays. We found that miR-
124 significantly reduced the activity of the luciferase gene
fused to the Sox9 30UTR by more than 70%, supporting the
notion that miR-124 can modulate Sox9 expression by binding
to its 30-UTR (Supplemental Fig. S2). Cheng et al. [42]
previously described a similar effect by using a different
reporter vector.
miR-124 is Up-Regulated in the Mouse Female Gonad
Between 11.5 and 13.5 dpc
In order to confirm the expression data reported by our
microarray screening for miR-124, we also performed Q-RT-
PCR analyses and in situ hybridization with mouse embryonic
gonads. Expression quantification by Q-RT-PCR confirmed
that miR-124 is up-regulated in the ovary but not in the testis
during the critical period of gonad differentiation between 11.5
and 13.5 dpc (Fig. 2A). According to miRBase, there are three
predicted precursor hairpin sequences of mmu-miR-124 in the
mouse genome, giving rise to the same mature sequence. The
identity of the miR-124 precursor(s) expressed in mouse
embryonic gonads was investigated by Q-RT-PCR with sets of
primers specific for the three miR-124 pre-miRNAs. Our
results revealed that all three miR-124 genes are expressed in
13.5 dpc mouse ovaries (mainly pre-miR-124-2) but not in
testes of the same developmental stage, where pre-miR-124-1
is absent and the other two precursors show low expression
levels (Fig. 2B). Expression values were always significantly
higher in females than in males for the three precursors (P ¼
FIG. 1. Heat map diagram showing miRNA expression profiles in
embryonic gonads during the period of sex determination. A two-way
hierarchical clustering of genes and samples identified five different gene
clusters. Clusters A and E include miRNAs showing no sex-specific down-
regulation (A) or up-regulation (E) during the transition between 11.5 and
13.5 dpc developmental stages; these genes are thus probably not
involved in sex determination. Cluster B contains three miRNAs up-
regulated in 13.5-dpc ovaries and down-regulated in 13.5 testes, with a
potential role in ovarian development. Cluster C includes 6 miRNAs up-
regulated in 13.5 dpc testes but not in 13.5 dpc ovaries, with a possible
role in testis development. Cluster D contains 11 miRNAs up-regulated in
13.5 dpc ovaries but not in 13.5 dpc testes, suggesting a role in ovarian
development.
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FIG. 2. Spatiotemporal expression pattern of miR-124 in mouse embryonic gonads during the period of sex determination. A) Q-RT-PCR (gray bars) and
miRNA microarray (white bars) data of miR-124 expression levels in male (M) and female (F) gonads at 11.5 and 13.5 dpc. miR-124 is sex-specifically up-
regulated in the 13.5 dpc female gonad. B) Q-RT-PCR quantification of the active miR-124 precursors 1, 2, and 3, in male (gray bars) and female (white
bars) embryonic gonads. Amplified products derived from all three precursors are mainly detected in the female samples. C–F) In situ hybridization
detection of miR-124 in developing mouse gonads. Hybridization signal is very weak in 11.5 dpc gonads of both sexes (C and E) and becomes prominent
in the coelomic epithelium of the XY gonad and the cortical region of the 13.5 dpc XX gonad (D and F, arrows in photomicrographs). G, gonad; M,
mesonephros. Dashed lines mark the border between the gonad and the mesonephros. Bar ¼ 300 lm for all images.
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0.015 for pre-miR-124-1; P ¼ 0.016 for pre-miR-124-2; P ¼
0.010 for pre-miR-124-3). In situ hybridization with a miR-
124-specific probe showed a faint or very weak expression in
both male and female gonads at 11.5 dpc (Fig. 2, C and E). At
13.5 dpc, miR-124 expression was prominently up-regulated in
the cortical region of the female gonad, whereas it was
sustained, albeit weak, in the coelomic epithelium of the male
gonad (Fig. 2, D and F).
Knock-Down of miR-124 Induces Up-Regulation of Sox9 in
13.5-dpc Embryonic XX Gonadal Cells
Because the 30UTR region of Sox9 contains a miR-124
target sequence, we hypothesize that miR-124 could be
responsible for maintaining down-regulation of Sox9 in the
female gonad from the sex differentiation stage onward. To test
this hypothesis, we transfected 13.5 dpc embryonic gonadal
cells with a specific miR-124-silencing probe, designated
antagomir-124 or Ant-124, that antagonizes the action of miR-
124. Q-RT-PCR analyses demonstrated a significant reduction
of endogenous miR-124 in cells transfected with the antagomir
(Fig. 3A). Immunofluorescence analysis revealed that the
SOX9 protein was absent in the nuclei of XX embryonic
gonadal cells when cells were untreated (Fig. 3B) or transfected
with an unrelated antagomir, Ant-144 (Fig. 3C). In contrast,
SOX9 expression was observed in XX gonadal cells
transfected with Ant-124 (Fig. 3D), such that they look similar
to control XY gonadal cells (Fig. 3E). Q-RT-PCR showed a
significant increase in Sox9 mRNA in XX gonadal cells
transfected with Ant-124 but neither in untreated XX cells nor
in those transfected with Ant-144 (Fig. 3F).
Overexpression of miR-124 Induces Down-Regulation of
Sox9 in Embryonic Chondrocytes but not in XY Gonadal
Cells
Based on our hypothesis, overexpression of miR-124 would
be expected to induce down-regulation of Sox9 in cells
expressing this gene naturally. To test this possibility, we
transfected both cultured chondrocytes and XY gonadal cells
with either a precursor miRNA expression vector containing
the mouse mmu-mir-124-2 gene or a negative control vector
containing a scrambled miRNA sequence. The levels of miR-
124 increased considerably in cells transfected with mmu-mir-
124-2, as measured by Q-RT-PCR (Fig. 4A). Immunofluores-
cence analyses demonstrated that the percentage of SOX9-
positive cells was significantly lower in chondrocytes trans-
fected with the mmu-mir-124-2 expression vector than in those
with the control vector. However, this effect was not observed
in XY gonadal cells; the percentage of cells expressing SOX9
did not decrease in the presence of the mmu-mir-124-2
expression vector (Fig. 4, B–F). Consistent with the results
of immunofluorescence studies, Q-RT-PCR analyses showed
that overexpression of mmu-mir-124-2 reduces the expression
levels of Sox9 mRNA in chondrocytes, whereas no significant
differences were observed in XY gonadal cells (Fig. 4G).
Because SOX9 expression is already robust and maintained by
several feedback loops in 13.5 dpc mouse embryonic testes,
miR-124 might not be able to efficiently overcome SOX9
expression. Therefore, we repeated the same set of experiments
using 11.5 dpc XY gonadal cells, where Sox9 transcription has
just started. However, we obtained similar results, confirming
the fact that overexpression of miR-124 is not sufficient to
affect SOX9 expression in XY gonadal cells (Supplemental
Fig. S3).
DISCUSSION
Despite the discovery of the mammalian testis-determining
gene SRY some 20 years ago [1, 2], it is thought that some
regulatory elements remain unknown, particularly those
involved in determining the ovary. Because miRNAs are
involved in many developmental processes, it is reasonable to
suspect that they may also have some role in gonad
development. Several recent studies strongly suggest that this
is the case in mammals [35–38]. Using miRNA microarray
technology, we identified 22 miRNAs (including mmu-miR-
126-5p, mmu-miR-103, and clusters B, C, and D) that are
either up- or down-regulated during the critical period of sexual
differentiation in a sex-specific manner, indicating that they
could participate in gonadal sex differentiation (Fig. 1).
Interestingly, coincident with ovarian cell determination at
13.5 dpc, most of them (16) are up-regulated in the ovary at
this stage, suggesting a potential role in ovarian development.
Using a clone-based miRNA amplification profiling meth-
od, Takada et al. [35] reported that some miRNAs show a sex-
dependent expression pattern in 13.5 dpc mouse gonads.
Concerning some of the miRNAs identified by those authors,
their results contradict those of our microarray-based screening.
Notably, Takada et al. reported that the expression of miR-124
is higher in developing testes than in ovaries [35]. However,
our data, particularly for miR-124 expression, have been
repeatedly validated by Q-RT-PCR and in situ hybridization,
which is not included in studies of Takada et al. In addition, a
recent publication reported that miR-202-5p/3p are differen-
tially expressed in the developing testis [43], thus coinciding
with our microarray data. In fact, miR-202-3p is included in
cluster C and miR-202-5p is in cluster E because the higher
expression detected in the testis did not exceed the SD . 0.5
threshold (Fig. 1). This represents further validation of our
microarray results.
Several findings support the fact that miR-124 could have
an important role during ovarian development. First, our
miRNA microarray profiling showed that miR-124 is differ-
entially up-regulated in the XX but not the XY gonad during
the transition from 11.5 to 13.5 dpc stages. Second, the
computational analysis for the miRNAs selected from our
microarray results identified potential targets for miR-124 in
the 30-UTR regions of four genes of the male pathway in both
human and mouse: Sox8 (the SRY-box containing gene 8),
Sox9, Dmrt1, and AR (androgen receptor). Third, Cheng et al.
[42] showed that the mouse miR-124 regulates adult
neurogenesis by repressing SOX9 production in the subven-
tricular zone of the brain [42], raising the possibility that this
miRNA could act also in the gonad. Overall, these findings
strongly suggested that the main role of miR-124 in the ovary
would be to inhibit the production of SOX9 protein.
To verify this hypothesis, miR-124 was knocked down or
overexpressed in primary cultures of embryonic gonadal cells.
Transfection with an miR-124-specific antagomir induced the
ectopic production of SOX9 protein in XX gonadal cells, as
well as a significant increase in Sox9 mRNA/transcript,
implying that miR-124 actively represses Sox9 in female
gonadal cells. The increased expression levels of Sox9 in XX
cells transfected with antagomir-124 are lower than those
observed in XY gonadal cells, suggesting that SRY-mediated
up-regulation of Sox9 is required to reach the male expression
level. In the developing mouse testis, Sox9 is activated
primarily, probably by SF1, in both XY and XX gonads prior
to sex differentiation [44]. At the time of sex determination,
Sox9 is up-regulated in the XY gonad by the combined,
synergistic action of SRY and SF1 on a testis-specific Sox9
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FIG. 3. Effects of miR-124 knockdown on Sox9 expression in 13.5 dpc XX embryonic gonadal cells. A) Q-RT-PCR confirmation of miR-124 knockdown;
transfection of XX cells with a miR-124-specific antagomir (ant-124) reduced the level of miR-124 similar to that found in XY cells, and significantly lower
(P , 0.01 in a one-tail Student t-test) than in either untreated XX cells or in those transfected with a negative control antagomir (ant-144). B–E)
Representative photomicrographs of transfected and control cultured cells. Cell nuclei are revealed by DAPI staining (blue). Transfected cells are marked
by FITC (green) provided by the silencing vector. The presence of SOX9 protein was detected by immunofluorescence (red). F) Q-RT-PCR analysis of the
expression levels of Sox9 in XX gonadal cells subjected to the miR-124 knockdown experiment. Sox9 expression was significantly increased (P, 0.05 in a
one-tail Student t-test) in XX cells transfected with the ant-124, reaching a level higher than that measured in either untreated XX cells or those transfected
with ant-144 but lower than the level observed in XY gonadal cells. All data are means 6 SEM from at least three independent experiments. Bar¼ 10 lm
for all images. *0.01 , P , 0.05; **0.001 , P , 0.01.
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FIG. 4. Effects of miR-124 overexpression in 13.5 dpc embryonic cells expressing Sox9. A) Q-RT-PCR confirmation of miR-124 overexpression in
chondrocytes and XY gonadal cells; in both cases, the cells transfected with the miR-124 expression vector (124) showed significantly increased levels of
the miR-124 (P , 0.05 in one-tail Student t-tests), compared with the control cells (i.e., cells either untreated [untr] or transfected with the scrambled
control vector [scrbl]). B–E) Representative micrographs of transfected and control cultured cells. Cell nuclei are revealed by DAPI staining (blue).
Transfected cells are marked by the GFP provided by the miR-124 expression vector. The presence of SOX9 protein was detected by immunofluorescence
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enhancer (TES) [22], while it is down-regulated in the XX
gonad. Afterward, Sox9 expression is maintained in the
developing testis despite the very transient nature of Sry
expression in mouse pre-Sertoli cells. Several molecular
mechanisms contribute to the maintenance of Sox9 expression,
as described earlier. Because XX gonadal cells lack Sry, the up-
regulation of Sox9 transcription in XX cells treated with
antagomiR-124 may be a secondary consequence of ectopic
production of SOX9 protein, presumably through the positive
feedback loops. Alternatively, miR-124 could repress both
Sox9 transcription and translation. These data suggest that
complete silencing of miR-124 in the XX gonads could be
capable of inducing a female-to-male sex reversal in vivo. In
this respect, a reasonable approach would be the transfection
(or electroporation) of intact gonad explants cultured ex vivo,
but we were unable to get positive results after repeated trials
using different techniques. These methods are too inefficient to
be useful, because it is usually only the outermost cells that
take up the DNA. Moreover, although similar numbers of cells
in XX and XY gonads were targeted prior to embryonic day
11.5, it is difficult to compare ovaries and testes after they
begin to become sexually dimorphic, given differences in size,
degree of epithelialization of the external layer, and formation
of epithelial testis cords in the last, which further reduce
transfection efficiencies. Hence, further research devoted to
produce transgenic mice expressing the antagomir is required.
Furthermore, we have shown that overexpression of miR-
124 induces repression of Sox9 in chondrocytes. However, the
reduction of SOX9 expression was not observed in XY gonadal
cells, even though the levels of ectopic miR-124 expression
were much higher than those of endogenous miR-124
expressed in XX gonadal cells (not shown). The results
obtained using 13.5 dpc XY gonadal cells were similar to those
observed in 11.5 dpc cells, indicating that the mechanisms
driving Sox9 expression are already robust by 11.5 dpc in
developing mouse testes. These findings suggest that the
distinct regulatory mechanisms controlling Sox9 expression
between chondrocytes and pre-Sertoli cells determine their
different response to the miR-124 overexpression experiments.
In chondrocytes, Sox9 expression is regulated by BMP and
transforming growth factor beta (TGFb) through a chondro-
genesis-specific enhancer (see reference [45] for a review), but
no positive feedback regulatory loop has been defined here.
Our results indicated that overexpression of miR-124 induces a
significant decrease of Sox9 expression at both protein and
mRNA levels in chondrocytes, which is consistent with the fact
that mammalian miRNAs act predominantly to decrease target
mRNA levels [46]. In chondrocytes, however, Sox9 expression
needs to be down-regulated to permit bone formation [47]. This
might imply that positive feedback regulation of Sox9 in
chondrocytes will be less robust than in Sertoli cells, where
high levels of SOX9 are maintained throughout life. Overall,
existing data show that several molecular regulatory mecha-
nisms have been selected to ensure Sox9 expression in Sertoli
cells.
In situ hybridization studies showed that miR-124 is present
mainly in the cortical region of the female gonad at 13.5 dpc
(i.e., the portion from which the ovarian tissue mostly develops
in mammals and other vertebrates [48] and also the region in
which the complete inhibition of Sox9 would be especially
necessary in the differentiating female gonad. The fact that
Sox9 is expressed mainly in the medulla of the developing
testis is not a valid argument against this hypothesis because
this is not the case in developing ovaries, where Sry is absent
and, thus, Sox9 is not up-regulated anywhere. Furthermore, it is
known that both pre-Sertoli and pregranulosa cells are derived
from cells originating in the coelomic epithelium of developing
gonads. These coelomic epithelial cells proliferate and migrate
into the gonad between 11.0 and 12.5 dpc [49, 50]. Distribution
of miR-124-expressing cells in the XX gonad is very similar to
that of proliferating cells, shown as bromodeoxyuridine
(BrdU)-positive cells by Schmahl et al. [50]. Hence, miR-124
may ensure that Sox9 is completely silenced in these
proliferating XX cortical cells, which might otherwise have
the potential to become Sertoli cells. In the coelomic
epithelium of the XY gonad, proliferating cells no longer
migrate into the gonad at 13.5 dpc, but they might retain a
potential to become ectopic Sox9-expressing Sertoli cells in the
region whose normal fate is to differentiate as the tunica
albuginea of the testis. miR-124 could thus secure Sox9
expression to be silenced in the coelomic epithelium as a back-
up mechanism to avoid this possible anomaly.
It is known that Dicer RNase III enzyme plays a crucial role
in processing pre-miRNA to produce miRNA. Two different
types of conditional Dicer1 null mutant mice have been
developed to study the function of miRNAs in somatic gonadal
cells. Papaioannou et al. [36] and Kim et al. [37] used an Amh-
Cre mouse strain (where the Cre recombinase is driven by the
anti-Mu¨llerian hormone gene promoter) to drive the Cre-LoxP-
mediated deletion of Dicer1 specifically in Sertoli cells at 14.5
dpc. Hence, no alteration of Dicer1 expression was induced in
the females derived from these crosses, as Amh is expressed
only in the Sertoli cells of the testis, shortly after the sex-
determination stage. Huang and Yao [38] performed a similar
experiment using Sf1-Cre mice to delete Dicer1 at earlier
stages in both sexes and found that, whereas testes degenerate
postnatally, ovaries appeared to be unaffected until the animals
died due to adrenal failure at 5 days postpartum. In both cases,
prenatal gonad development appeared to be completely normal.
These results led to the surprising conclusion that no miRNA is
required for normal ovarian development, but the authors did
not provide proof that miRNAs had been completely
eliminated and, most importantly, when the miRNA decay
eventually took place. Hence, definite experiments of Dicer
genetic ablation, using more efficient Cre drivers, remain to be
done with undifferentiated XX and XY gonads.
We report here the first evidence suggesting that miRNAs
play a role in the early steps of ovarian development. We have
shown that inhibition of miR-124 in XX gonadal cells results in
up-regulation of Sox9, indicating that this miRNA is at least
partly responsible for Sox9 repression in the female gonad.
Two sets of evidence strongly indicate that Sox9 must be
repressed in the female gonad in order to avoid a female-to-
male sex reversal; first, it is known that XX gonads
overexpressing Sox9 develop as testes [9, 10], and second,
Sox9 is down-regulated in the female gonad at the time of sex
determination [51, 52]. Wnt4 plays a role in this down-
regulation because Sox9 is transiently up-regulated in the
3
(red). F) Percentage of transfected chondrocytes and XY gonadal cells that express Sox9. miR-124 transfection (124) induces a significant reduction in the
percentage of chondrocytes expressing SOX9, compared with the control (scrbl), but has no similar effect in XY gonadal cells. G) Q-RT-PCR measurement
of the levels of Sox9 mRNA in transfected chondrocytes and XY gonadal cells. Consistent with SOX9 immunostaining, overexpression of miR-124
significantly reduced the Sox9 expression levels in chondrocytes but not in XY gonadal cells compared with either untreated (untr) or transfected cells with
the control vector (scrbl). Bar ¼ 10 lm for all images. *0.01 , P , 0.05.
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gonads of Wnt4/ null mutant XX mice. However, complete
sex reversal is not observed, although the mutant ovary is
masculinized, suggesting that an additional ovary-promoting or
anti-testis factor(s) may also be involved (see reference [19] for
a review). Here we provide evidence that miR-124 is likely to
be one such factor reinforcing the ovarian developmental
pathway by repressing Sox9 in the XX mouse gonad at the time
of sex determination (Supplemental Fig. S4). Further analysis
of the other miRNAs identified in this study will probably
permit the discovery of new pieces of the complex puzzle of
genes controlling mammalian sex determination.
In conclusion, the sex-specific differential expression
pattern of several miRNAs during the critical period of sex
determination, along with the identification of potential targets
for these miRNAs in the 30-UTR of master genes that control
this process, suggest that miRNAs play critical roles in
regulating these genes in mammals. Inhibition of miR-124 in
XX gonadal cells induces the ectopic expression of Sox9,
indicating that this miRNA may be responsible for Sox9 down-
regulation in female gonads at the critical time of sex
determination. The ectopic overexpression of miR-124 reduces
the levels of Sox9 expression in chondrocytes but not in XY
gonadal cells, demonstrating that the expression of this gene is
very robust in the testis since the earliest stages of gonadal
differentiation and that different regulatory mechanisms
operate for this gene in these two cell types.
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